Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-08 4:01 pm Sale | 2024-03-31 | 13G | Poseida Therapeutics, Inc. PSTX | NOVARTIS PHARMA AG | 0 0.000% | -5,908,089 (Position Closed) | Filing History |
| 2023-05-26 4:17 pm Unchanged | 2023-05-10 | 13D | GAMIDA CELL LTD GMDAQ | NOVARTIS PHARMA AG | 4,336,759 4.100% | 0 (Unchanged) | Filing History |
| 2023-03-03 4:02 pm Sale | 2022-12-30 | 13D | GAMIDA CELL LTD GMDAQ | NOVARTIS PHARMA AG | 4,336,759 5.800% | -857,295 (-16.51%) | Filing History |
| 2022-12-19 4:21 pm Purchase | 2022-12-09 | 13G | Erasca, Inc. ERAS | NOVARTIS PHARMA AG | 12,307,692 8.200% | 12,307,692 (New Position) | Filing History |
| 2022-06-27 4:37 pm Purchase | 2022-06-15 | 13G | Precision BioSciences, Inc. DTIL | NOVARTIS PHARMA AG | 413,581 16.600% | 413,581 (New Position) | Filing History |
| 2021-10-08 4:07 pm Purchase | 2021-09-01 | 13G | SomaLogic, Inc. SLGC | NOVARTIS PHARMA AG | 10,367,340 5.700% | 10,367,340 (New Position) | Filing History |
| 2021-03-11 4:35 pm Unchanged | 2021-03-01 | 13D | GAMIDA CELL LTD GMDAQ | NOVARTIS PHARMA AG | 5,194,054 8.800% | 0 (Unchanged) | Filing History |
| 2021-02-23 7:57 pm Sale | 2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | NOVARTIS PHARMA AG | 0 0.000% | -1,458,257 (Position Closed) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | NOVARTIS PHARMA AG | 125,000 1.000% | 116,667 (+1400.00%) | Filing History |
| 2021-02-12 4:24 pm Purchase | 2020-12-31 | 13G | Poseida Therapeutics, Inc. PSTX | NOVARTIS PHARMA AG | 5,908,089 9.600% | 5,908,089 (New Position) | Filing History |
| 2020-08-14 4:49 pm Purchase | 2019-06-28 | 13D | GAMIDA CELL LTD GMDAQ | NOVARTIS PHARMA AG | 5,194,054 10.300% | 1,919 (+0.04%) | Filing History |
| 2020-08-14 4:32 pm Unchanged | 2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | NOVARTIS PHARMA AG | 1,458,257 7.500% | 0 (Unchanged) | Filing History |